# Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

> Research article (Journal of Clinical Oncology, 2022) · cited 16× · AI/ML

**Wikidata**: [openalex:W4281839742](https://www.wikidata.org/wiki/openalex:W4281839742)  
**Source**: https://4ort.xyz/entity/ulixertinib-in-patients-with-tumors-with-mapk-pathway-alterations-results-from-nci-cog-pediatric-match-trial-arm-j-apec1